Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in Orange, CA
NPI: 1366594855Primary Practice Location
UNIVERSITY OF CALIFORNIA IRVINE MEDICAL CENTER
101 The City Dr S, Orange, CA
Primary Employer
UCI Department of Medicine
medschool.uci.edu
HQ Phone
Get M.D. Fa-Chyi's Phone Numberphone_androidMobile
Get M.D. Fa-Chyi's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
NM State Medical License
CA State Medical License
1993 - 2025
NM State Medical License
1999 - 2018
TX State Medical License
1997 - 2004
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Hematology and Medical Oncology
1994 - 1997
University of Texas Southwestern Medical Center
Residency • Internal Medicine
1991 - 1994
Saint Louis University School Of Medicine
slu.edu
Medical School
Until 1991
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 108 | 538 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 52 | 77 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 34 | 34 |
| 4 | 99221Initial hospital inpatient care, typically 30 minutes per day | 11 | 11 |
90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies
Authors: Tomislav Dragovich, Maeve Lowery
Publication Date: 2015-09
Longterm clinical remission of oral and cutaneous pemphigus with thalidomide.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Int J Dermatol
Lead Sponsor: New Mexico Cancer Research Alliance
Intervention / Treatment: DRUG: Irinotecan & Capecitabine
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Capecitabine, DRUG: Fluorouracil, DRUG: Trametinib, DRUG: Leucovorin Calcium
Lead Sponsor: Eastern Cooperative Oncology Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: cetuximab, BIOLOGICAL: ramucirumab, DRUG: irinotecan hydrochloride
